American Academy of Pediatrics Committee on Fetus and Newborn

Cochrane Neonatal Reviews cited in guidelines from the American Academy of Pediatrics Committee on Fetus and Newborn

Guideline name:

  1. Assessment and management of inguinal hernia in infants  
  2. Hospital discharge of the high-risk neonate
  3. Hypothermia and neonatal encephalopathy
  4. Neonatal drug withdrawal  
  5. Noninvasive respiratory support
  6. Patent ductus arteriosus in preterm infants
  7. Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia
  8. Prevention and management of procedural pain in the neonate: an update
  9. Respiratory support in preterm infants at birth
  10. Skin-to-skin care for term and preterm infants in the neonatal ICU
  11. Strategies for prevention of health care-associated infections in the NICU
  12. Surfactant replacement therapy for preterm and term neonates with respiratory distress
  13. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate
  14. Use of inhaled nitric oxide in preterm infants

(To read the guideline, click on the guideline title. To read the review, click on the review title.)

Assessment and management of inguinal hernia in infants, 2012 

  1. Regional (spinal, epidural, caudal) versus general anaesthesia in preterm infants undergoing inguinal herniorrhaphy in early infancy

Hospital discharge of the high-risk neonate, 2008

  1. Early discharge with home support of gavage feeding for stable preterm infants who have not established full oral feeds

Hypothermia and neonatal encephalopathy, 2014

  1. Cooling for newborns with hypoxic ischaemic encephalopathy

Neonatal drug withdrawal, 2012  

  1. Opiate treatment for opiate withdrawal in newborn infants
  2. Sedatives for opiate withdrawal in newborn infants

Noninvasive respiratory support, 2016 

  1. Continuous positive airway pressure versus theophylline for apnea in preterm infants
  2. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome
  3. High flow nasal cannula for respiratory support in preterm infants
  4. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation
  5. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity

Patent ductus arteriosus in preterm infants, 2016

  1. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants

Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia, 2010

  1. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants
  2. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants
  3. Early (<8 days) corticosteroids for preventing chronic lung disease in preterm infants
  4. Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants
  5. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants
  6. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates
  7. Moderately early (7–14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants

Prevention and management of procedural pain in the neonate: an update, 2016

  1. Breastfeeding or breast milk for procedural pain in neonates
  2. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants
  3. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit
  4. Opioids for neonates receiving mechanical ventilation
  5. Paracetamol (acetaminophen) for prevention or treatment of pain in newborns
  6. Skin-to-skin care for procedural pain in neonates
  7. Sucrose for analgesia in newborn infants undergoing painful procedures
  8. Topical anaesthesia for needle-related pain in newborn infants

Respiratory support in preterm infants at birth, 2014

  1. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS
  2. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome
  3. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants

Skin-to-skin care for term and preterm infants in the neonatal ICU, 2015

  1. Kangaroo mother care to reduce morbidity and mortality in low birthweight infants
  2. Skin-to-skin care for procedural pain in neonates

Strategies for prevention of health care-associated infections in the NICU, 2012

  1. Emollient ointment for preventing infection in preterm infants
  2. Gowning by attendants and visitors in newborn nurseries for prevention of neonatal morbidity and mortality
  3. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants
  4. Tracheal suctioning without disconnection in intubated ventilated neonates
  5. Vancomycin for prophylaxis against sepsis in preterm neonates

Surfactant replacement therapy for preterm and term neonates with respiratory distress, 2014

  1. Animal derived surfactant extract for treatment of respiratory distress syndrome
  2. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS
  3. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome
  4. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome
  5. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome
  6. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome
  7. Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome
  8. Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome
  9. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants
  10. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants
  11. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants
  12. Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome
  13. Surfactant for bacterial pneumonia in late preterm and term infants
  14. Surfactant for meconium aspiration syndrome in full term infants
  15. Surfactant for pulmonary haemorrhage in neonates
  16. Synthetic surfactant for respiratory distress syndrome in preterm infants

Surfactant-replacement therapy for respiratory distress in the preterm and term neonate, 2008

  1. Continuous distending pressure for respiratory distress syndrome in preterm infants
  2. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS
  3. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome
  4. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome
  5. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants
  6. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants
  7. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants
  8. Surfactant for meconium aspiration syndrome in full term infants
  9. Synthetic surfactant for respiratory distress syndrome in preterm infants
  10. Therapeutic lung lavage for meconium aspiration syndrome in newborn infants

Use of inhaled nitric oxide in preterm infants, 2014

  1. Inhaled nitric oxide for respiratory failure in preterm infants